16th JBF Symposium
Advanced Search

Session Details

Symposium

[D2-A1]Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment

Tue. Mar 4, 2025 9:10 AM - 10:10 AM JST
Tue. Mar 4, 2025 12:10 AM - 1:10 AM UTC
Medium Hall(2nd Floor)
Chairman:Hiroyuki Shimizu(Mitsubishi Tanabe Pharma Corporation), Hisanori Hara(B2S Life Sciences)
9:10 AM - 9:40 AM JST(12:10 AM - 12:40 AM UTC)

[D2-A1-01]Rational is not Radical – A Scientific Perspective on Immunogenicity Risk and Assessment

*Lauren Stevenson1 (1. Immunologix Laboratories)
9:40 AM - 10:10 AM JST(12:40 AM - 1:10 AM UTC)

[D2-A1-02]Draft Guideline for Immunogenicity Assessment of Biopharmaceuticals

*Akiko Ishii-Watabe1 (1. National Institute of Health Sciences)
Back to Category List